scispace - formally typeset
C

Craig F. Donatucci

Researcher at Eli Lilly and Company

Publications -  119
Citations -  4746

Craig F. Donatucci is an academic researcher from Eli Lilly and Company. The author has contributed to research in topics: Erectile dysfunction & Tadalafil. The author has an hindex of 35, co-authored 119 publications receiving 4509 citations. Previous affiliations of Craig F. Donatucci include University of California, San Francisco & Durham University.

Papers
More filters
Journal ArticleDOI

Summary of the recommendations on sexual dysfunctions in men

Francesco Montorsi, +42 more
TL;DR: Specific evaluation, treatment guidelines, and algorithms were developed for every sexual dysfunction in men, including erectile dysfunction; disorders of libido, orgasm, and ejaculation; Peyronie's disease; and priapism.
Journal ArticleDOI

alpha1-ADRENERGIC RECEPTOR SUBTYPES IN HUMAN DETRUSOR

TL;DR: Human detrusor contained two alpha1AR subtypes (alpha1d > alpha1a), a finding that is different from rat, another commonly used animal model, which suggests bladder alpha1dARs may provide a potentially novel mechanism underlying these therapeutic benefits.
Journal ArticleDOI

Pharmacotherapy for erectile dysfunction.

TL;DR: PDE5 inhibitors are effective, safe, and well-tolerated therapies for the treatment of men with erectile dysfunction, and Apomorphine, intracavernosal injection therapy with alprostadil, and intraurethral al Prostadil are all effective andWell-Tolerated treatments for men with erection problems.
Journal ArticleDOI

The Role of Cyclic Adenosine Monophosphate, Cyclic Guanosine Monophosphate, Endothelium and Nonadrenergic, Noncholinergic Neurotransmission in Canine Penile Erection

TL;DR: The results suggest that both the cholinergic and NANC neuroeffectors and the sinusoidal endothelium are involved in erection and imply that the neuronal nitric oxide/cyclic GMP system is the most likely pathway for penile smooth muscle relaxation and erection.